On May 8, the U.S. Food and Drug Administration (FDA) approved the Senza spinal cord stimulation (SCS) system to help manage chronic intractable pain of the trunk and/or limbs. The system can reduce pain without paresthesia by providing high frequency stimulation (at 10 KHz) and low stimulation amplitudes. Read more.

FDA approves new spinal cord stimulation system for pain

Long-term depression increases stroke risk

New evidence that MRI may help predict breast cancer in some women

It’s YOU We Want to Celebrate!!

Letter to the Editor: A case study of a managers’ workshop

Headlines from the Hill

Nursing practice and work environment

Issues up close

May 2015 Vol. 10 No. 5

Your path to becoming a nurse educator

The essence of nursing

Creating the environment for nursing excellence

Keeping patients safe from falls and pressure ulcers

Preventing high-alert medication errors in hospital patients

How to get off the anger-go-round

The pressure is on

How nurses can help reduce hospital readmissions

Attitude adds to a toxic work environment

Managing chest tubes: Air leaks and unplanned tube removal

A bold move to improve collaboration

The Essence of Nursing – Key points

Enhance patient engagement through sharing

Dedicated education units: An innovative model for clinical education

Reducing functional decline in hospitalized older

In with care boards, out with care plans

Flipping your classroom

Why long-term care is an excellent clinical learning environment

From your ANA President

The importance of executive presence

The magic of kaizen

FDA approves Raplixa to help control bleeding during surgery

Perception of care for the dying worsens

Letter to the Editor – Recognizing Heart Failure Symptoms Can Improve Patient Self-Management

Differentiating statistical significance and clinical significance

Excessive opioids lead to a close call for a burn patient

FDA approves generic Abilify